Johnson & Johnson as of March 31, 2026
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 16 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 39.6 | $258M | 2.4M | 105.40 | |
| Nanobiotix Sponsored Ads (NBTX) | 26.6 | $174M | 5.6M | 30.87 | |
| Meiragtx Holdings (MGTX) | 8.8 | $58M | 6.6M | 8.66 | |
| Rapport Therapeutics (RAPP) | 8.6 | $56M | 1.8M | 31.29 | |
| CVRX (CVRX) | 5.8 | $38M | 4.0M | 9.46 | |
| Contineum Therapeutics Cl A (CTNM) | 4.0 | $26M | 2.0M | 13.06 | |
| Legend Biotech Corporation Sponsored Ads (LEGN) | 2.3 | $15M | 815k | 18.09 | |
| Xencor (XNCR) | 1.4 | $9.0M | 748k | 12.06 | |
| Procept Biorobotics Corp (PRCT) | 1.4 | $9.0M | 358k | 25.01 | |
| Fate Therapeutics (FATE) | 0.6 | $4.1M | 3.4M | 1.20 | |
| Neumora Therapeutics (NMRA) | 0.6 | $3.6M | 1.8M | 1.95 | |
| Rallybio Corp (RLYB) | 0.2 | $1.4M | 153k | 8.97 | |
| Vor Biopharma Com New (VOR) | 0.1 | $959k | 54k | 17.84 | |
| D Fluidigm Corp Del (LAB) | 0.0 | $287k | 312k | 0.92 | |
| Nano-X Imaging Ord Shs (NNOX) | 0.0 | $190k | 84k | 2.27 | |
| Adicet Bio Com New (ACET) | 0.0 | $155k | 23k | 6.81 |
